Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QARIN 1
NCT05128903Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jul 2022
- Primary completion
- Oct 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DPA-714 in medulloblastoma, sponsored by St. Jude Children's Research Hospital. Started Jul 2022; status: active, not recruiting.
02
Drugs
DPA-714
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT05128903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05128903.